BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6124418)

  • 1. Cyclic nucleotides and somatomedin action in cartilage.
    Stuart CA; Vesely DL; Provow SA; Furlanetto RW
    Endocrinology; 1982 Aug; 111(2):553-8. PubMed ID: 6124418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclic nucleotides on deoxyribonucleic acid synthesis in hypophysectomized rat cartilage: stimulation of thymidine incorporation and potentiation of the action of somatomedin by analogs of adenosine 3',5'-monophosphate or a cyclic nucleotide phosphodiesterase inhibitor.
    Bomboy JD; Salmon WD
    Endocrinology; 1980 Aug; 107(2):626-32. PubMed ID: 6248332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative involvement of cyclic nucleotide phosphodiesterases and adenylyl cyclase on adrenocorticotropin-induced increase of cyclic adenosine monophosphate in rat and human glomerulosa cells.
    Côté M; Payet MD; Rousseau E; Guillon G; Gallo-Payet N
    Endocrinology; 1999 Aug; 140(8):3594-601. PubMed ID: 10433216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro.
    Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U
    Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The cyclic nucleotide system in various sections of the dog myocardium in experimental infarction].
    Frolova NIu; Printsev MD; Tret'iakov AV; Kozhetiakin LA; Korovkin BF
    Vopr Med Khim; 1989; 35(1):64-8. PubMed ID: 2568032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatomedin-C as an amplifier of follicle-stimulating hormone action: enhanced accumulation of adenosine 3',5'-monophosphate.
    Adashi EY; Resnick CE; Svoboda ME; Van Wyk JJ
    Endocrinology; 1986 Jan; 118(1):149-55. PubMed ID: 3000731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased guanylate cyclase activity and guanosine 3',5'-monophosphate content in ethionine-induced hepatomas.
    DeRubertis FR; Craven P
    Cancer Res; 1977 Jan; 37(1):15-21. PubMed ID: 11887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of the components of the cyclic nucleotide system in N-nitrosodiethylamine-induced hepatic carcinogenesis in rats].
    Antonenko SG; Berdinskikh NK; Mishnaevskaia EG
    Eksp Onkol; 1990; 12(5):18-21. PubMed ID: 2171896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase.
    Drewett JG; Ziegler RJ; Trachte GJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):689-96. PubMed ID: 1346640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP.
    DeRubertis FR; Craven PA
    Metabolism; 1976 Dec; 25(12):1611-25. PubMed ID: 186692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of cyclic nucleotides and IP(3) in the regulation of luminescence in the brittlestar Amphipholis squamata (Echinodermata).
    De Bremaeker N; Dewael Y; Baguet F; Mallefet J
    Luminescence; 2000; 15(3):159-63. PubMed ID: 10862144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of guanylate cyclase activity and reduction of adenylate cyclase activity by granulocyte-macrophage colony-stimulating factor in human blood neutrophils.
    Coffey RG; Davis JS; Djeu JY
    J Immunol; 1988 Apr; 140(8):2695-701. PubMed ID: 2895792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The content and metabolism of cyclic adenosine 3', 5'-monophosphate and cyclic guanosine 3', 5'-monophosphate in adenocarcinoma of the human colon.
    DeRubertis FR; Chayoth R; Field JB
    J Clin Invest; 1976 Mar; 57(3):641-9. PubMed ID: 175089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
    Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
    Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclic nucleotides and their associated enzymes in 9,10-dimethyl-1,2-benzanthracene-induced mammary tumors of rats.
    Rillema JA; Mulder JA; Anderson LD
    Cancer Res; 1978 Mar; 38(3):741-4. PubMed ID: 23896
    [No Abstract]   [Full Text] [Related]  

  • 16. [Concentration of cyclic nucleotides, activity of adenylate cyclase, 3',5'-AMP phosphodiesterase and guanylate cyclase in plasma membranes from liver and hepatomas of different degrees of malignancy].
    Davydova SIa; Vetchinin SS
    Vopr Med Khim; 1978; 24(5):652-7. PubMed ID: 30212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide metabolism in the mouse spleen after treatment with tilorone hydrochloride.
    Römer W; Zschiesche W
    Acta Biol Med Ger; 1979; 38(5-6):791-4. PubMed ID: 43058
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclic AMP, adenylate cyclase and cyclic AMP-phosphodiesterase activities in diabetic rat adipocytes.
    Chiappe de Cingolani GE
    Acta Physiol Pharmacol Latinoam; 1986; 36(1):39-46. PubMed ID: 3020875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells.
    Yao J; Hiramatsu N; Zhu Y; Morioka T; Takeda M; Oite T; Kitamura M
    J Am Soc Nephrol; 2005 Jan; 16(1):58-67. PubMed ID: 15537869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.